ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Lundbeck Cuts Jobs, Seeks External R&D

by Michael McCoy
October 4, 2010 | APPEARED IN VOLUME 88, ISSUE 40

Danish drugmaker H. Lundbeck will eliminate a total of 50 positions at its research centers in Denmark and the U.S. as part of a refocusing of its R&D strategy. The company, which specializes in brain diseases, says its research will increasingly be based on the relationship between the biology of a disease and its symptoms. It adds that partnerships with universities and other companies, already important, will receive even higher priority in the future.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment